Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

John Diekman - aVenture Research

John Diekman

AddedMar 31, 2024

UpdatedOct 12, 2026

John Diekman

John Diekman

Co-Founder, 5AM Ventures

John Diekman's Career

Zai Lab

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Public$1.7BShanghai, CN

Board Member· Board

5AM Ventures

Investment FirmMenlo Park, CA, US

Co-Founder

Bay City Capital

Investment FirmSan Francisco, CA, US

Co-Founder

Igenica

Series C$80.6MBurlingame, CA, US

Board Member· Board

Wildcat Discovery Technologies

Series D$160MSan Diego, CA, US

Board Member· Board

Phenomix

$106.6MSan Diego, CA, US

Board Member· Board

Scripps Research Institute

Series A$370.8MLos Angeles, CA, US

Board Member· Board

People Similar to John Diekman

Bill BowesCo-Founder · U.S. Venture Partners

Marvin H. CaruthersCo-Founder · Amgen Ventures

Robert WilliamsBoard Member · Amgen Ventures

Leroy HoodCo-Founder · Amgen Ventures

Fred HassanBoard Member · Amgen Ventures

Elliott SigalBoard Member · Amgen Ventures

David WetherellFounder · GBP Capital

Leadership at Zai Lab

Scott MorrisonBoard Member

Peter WirthBoard Member

Samantha DuBoard Member

Nisa LeungBoard Member

Similar to Zai Lab

Shanghai Junshi Biosciences CoShanghai, CNBiopharmaceuticals, Drugsest. 2012Shanghai Junshi Biosciences CoShanghai, CN · est. 2012

Shanghai-based Junshi Biosciences develops and globally markets biopharmaceuticals, including small molecule drugs.

Leadership at Phenomix

Damion WickerBoard Member

Pete SchultzFounder

James A HarperBoard Member

Similar to Phenomix

Phenomix SciencesRochester, MN, USBiotechest. 2017Phenomix SciencesRochester, MN, US · est. 2017

Phenomix Sciences: A biotech firm excelling in life science, metabolomics, and genomics.

Denovo BiopharmaSan Diego, CA, USBiotechnology, Drug Developmentest. 2011Denovo BiopharmaSan Diego, CA, US · est. 2011

Denovo Biopharma, LLC: A private US biotech firm specializing in personalized drug development solutions.

Series D · CN¥1.2B36

PhylosLexington, KY, USBiopharmaceuticalsPhylosLexington, KY, US

Phylos: A crop science firm committed to discovering and developing innovative biopharmaceuticals.

Series B · $25M6

NexeptionMalvern, AR, USBiopharmaceuticalsest. 2013NexeptionMalvern, AR, US · est. 2013

NeXeption, LLC: A biopharmaceutical management firm expert in capital raising, strategic partnerships, and product advancement.

Series A · $21.5M14

Leadership at 5AM Ventures

Andy SchwabCo-Founder

Similar to 5AM Ventures

Versant VenturesSan Francisco, CA, USest. 1999Versant VenturesSan Francisco, CA, US · est. 1999

Versant Ventures: A leading healthcare investment firm, focusing on novel therapeutic biotechnology.

Investment Firm68

Amkey VenturesFremont, CA, USest. 2001Amkey VenturesFremont, CA, US · est. 2001

Amkey Ventures, LLC: A US-based venture capital firm specializing in seed and start-up biotech investments.

Investment Firm6

Atlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29

Asset Management VenturesPalo Alto, CA, USest. 1965Asset Management VenturesPalo Alto, CA, US · est. 1965

Asset Management Ventures: A US-based venture capital firm investing in early-stage IT and health science tech.

Investment Firm36

Leadership at Bay City Capital

Frederick Bernard CravesCo-Founder

Similar to Bay City Capital

Mission Bay CapitalSan Francisco, CA, USest. 2009Mission Bay CapitalSan Francisco, CA, US · est. 2009

Mission Bay Capital: A venture capital firm specializing in early-stage investments.

Investment Firm5

Baystar CapitalLarkspur, CA, USest. 1998Baystar CapitalLarkspur, CA, US · est. 1998

BayStar Capital, a private equity fund, invests in growth-stage tech and life sciences companies, with over $250M invested since 1998.

Investment Firm7

Bay PartnersMenlo Park, CA, USest. 1978Bay PartnersMenlo Park, CA, US · est. 1978

Bay Partners: A venture capital firm investing in IT and healthcare businesses.

Investment Firm5

BCM TechnologiesHouston, TX, USest. 1983BCM TechnologiesHouston, TX, US · est. 1983

BCM Technology, Inc. is a venture capital firm specializing in early-stage investments in life sciences and tech startups.

Investment Firm14

Leadership at Igenica

Mark A. GoldsmithBoard Member

Robert SchreiberBoard Member

David GoeddelBoard Member

Carl L. GordonBoard Member

Similar to Igenica

MacroGenicsRockville, MD, USest. 2000MacroGenicsRockville, MD, US · est. 2000

US-based MacroGenics, Inc. develops novel biologics for cancer, autoimmune disorders, and infectious diseases.

Public · $165.9M357

Leadership at Wildcat Discovery Technologies

Tom BaruchBoard Member

Troy WilsonFounder

Mike WillisBoard Member

C. Robert KidderBoard Member

Mark GresserCEO

Similar to Wildcat Discovery Technologies

Stratus MaterialsPittsburgh, PA, USBattery Materials, Cathodesest. 2022Stratus MaterialsPittsburgh, PA, US · est. 2022

Pittsburgh-based Stratus Materials manufactures manganese-rich, cobalt-free cathodes for lithium-ion batteries.

Series A · $12M30

Leadership at Scripps Research Institute

Donna BlackmondBoard Member

Ellen Browning ScrippsFounder

Kirill MartemyanovBoard Member

Patrick GriffinBoard Member

Matthew D. DisneyBoard Member

Similar to Scripps Research Institute

Scripps Translational Science InstituteLos Angeles, CA, USGenomic Researchest. 2006Scripps Translational Science InstituteLos Angeles, CA, US · est. 2006

LA-based Scripps Translational Science Institute pioneers genomic advances into diagnostics and treatments, with a focus on lifestyle changes.

Innovent BiologicsSuzhou, Jiangsu, CNAntibody Drugs, Pharmaceuticalsest. 2011Innovent BiologicsSuzhou, Jiangsu, CN · est. 2011

Innovent Biologics, a Chinese biopharmaceutical firm, develops and distributes monoclonal antibody drugs for various diseases.

Public · $868.3M5.6k

Livzon MabpharmZhuhai, Guangdong, CNAntibody Drugs, Pharmaceuticalsest. 2010Livzon MabpharmZhuhai, Guangdong, CN · est. 2010

China-based pharmaceutical company specializing in research, development, production, and sales of pharmaceutical products.

BioRay PharmaceuticalsShanghai, CNMedicines, Pharmaceuticalsest. 2019BioRay PharmaceuticalsShanghai, CN · est. 2019

Leading biopharmaceutical company in China, specializing in immune-mediated diseases and cancer treatments. Visit www.bioraypharm.com.

Public · CN¥2.5B3k

IGM BiosciencesMountain View, CA, US

Antibodies, Therapeuticsest. 2010

IGM BiosciencesMountain View, CA, US · est. 2010

IGM Biosciences, a US-based clinical-stage biotech firm, specializes in creating and enhancing IgM antibodies for improved therapeutic applications.

Public · $699.3M258

ImmuneXciteLexington, KY, USAntibodies, Therapeuticsest. 2007ImmuneXciteLexington, KY, US · est. 2007

US-based ImmuneXcite enhances therapeutic monoclonal antibodies' efficacy with its platform technology.

Series A · $15.7M10

Ingenia TherapeuticsWatertown, MA, USAntibodies, Therapeuticsest. 2018Ingenia TherapeuticsWatertown, MA, US · est. 2018

Ingenia Therapeutics: A biotech startup developing therapeutic antibodies for cancer and chronic diseases.

Series A · $11.7M12

Anovion Battery MaterialsChicago, IL, USBattery Materialsest. 2022

Anovion Battery MaterialsChicago, IL, US · est. 2022

Anovion: North America's leader in producing synthetic graphite for battery materials.

$117M30

HiT NanoBordentown, NJ, USBattery Cathodesest. 2018HiT NanoBordentown, NJ, US · est. 2018

HiT Nano: A Princeton spin-off, scaling up sustainable, low-cost Li-ion battery cathodes.

Pre-Seed · $85k5

Automat SolutionsFremont, CA, USBattery Materialsest. 2019Automat SolutionsFremont, CA, US · est. 2019

Automat Solutions: Accelerating materials innovation for the global lithium battery market from Fremont, CA.

Seed · $224.4k7

Novartis Institutes For Biomedical ResearchCambridge, MA, USDrug Discoveryest. 2002

Novartis Institutes For Biomedical ResearchCambridge, MA, US · est. 2002

Novartis Institutes For Biomedical Research: A noncommercial research organization founded in 2002.

10k

UC San DiegoLa Jolla, CA, USResearchest. 1960UC San DiegoLa Jolla, CA, US · est. 1960

UC San Diego is a public research university providing higher education, scientific research, and health care.

Institute for Systems BiologySeattle, WA, USBiomedical Researchest. 2000Institute for Systems BiologySeattle, WA, US · est. 2000

ISB: A non-profit institute conducting biomedical research for cures and prevention of diseases and cancers.